BPC-157 + TB-500 + GHK-Cu Research Reference

Catalog classification, reference sizes, lab math links, and source-backed data. Educational use only — not medical advice.

Researched for: multipeptide tissue remodeling research

Structural Blend blend Blend verified

Also known as: BPC/TB/GHK, Tri-compound copper blend

Quick Facts

Reference Sizes
70 mg total (10 mg BPC-157 + 10 mg TB-500 + 50 mg GHK-Cu)
Components
BPC-157 + TB-500 + GHK-Cu
Calculator
Preset available
Storage
Use source-label storage wording. Track lot, storage location, and open/reconstitution date.
Solubility
No peer-reviewed compatibility study for the 10:10:50 mixture; a clear solution does not prove chemical stability

Blend Components

This entry is a multi-compound blend. Each component can be opened individually in the reconstitution calculator.

Component
BPC-157
Calculator Profile
Component
TB-500
Calculator Profile
Component
GHK-Cu
Calculator Profile
Open All in Blend Calculator

Component amounts shown are arithmetic starters based on equal distribution. Edit values in the calculator before saving.

Catalog Description

The GLOW blend is a market-standard 70 mg co-lyophilized vial, usually 10 mg BPC-157, 10 mg TB-500, and 50 mg GHK-Cu. Each component has a distinct and uneven evidence base, and TB-500 is not interchangeable with full-length thymosin beta-4. No controlled study evaluates the three-component fixed blend, its ratio, compatibility, or injection safety.

Catalog descriptions reflect research context only. Not a medical claim or treatment recommendation.

Research Profile

Half-Life
No fixed-blend pharmacokinetic study
Onset
Not established
Administration Routes (Research)
SC in marketed or community products onlyNo validated clinical route

Reported Research Effects

Reported Research Side Effects

Data source: FDA safety materials, component literature, current vendors, COAs, and community checks

Reflects preclinical/research literature context only. Not a medical claim, dosing instruction, or treatment recommendation.

Research Protocols Reported in the Literature

Research Notes

The 70 mg size is genuinely common and independently measurable by component-specific content testing, but the product remains a commercial formulation without clinical evidence.

Supplementary research context only. Not medical advice or a treatment recommendation.

Sources

FDA Category 2 bulk substances with significant compounding safety concerns — U.S. Food and Drug Administration
https://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/PharmacyCompounding/UCM467373.pdf
BPC-157 FDA briefing document — U.S. Food and Drug Administration
https://www.fda.gov/media/193343/download

Suggest a community source

Found a relevant Reddit or forum thread about this compound? Suggest it below. Every suggestion is reviewed by an editor before it appears -- nothing is published automatically.

Related Research Articles

Published articles on this site that mention BPC-157 + TB-500 + GHK-Cu or one of its catalog aliases.

Related Research Tools

Research Use Only. All content is for educational and research reference only. Not medical advice, a treatment recommendation, or guidance on human use. Compounds are not FDA-approved drugs unless specifically noted.

Scroll to Top